The disclosure generally relates to medical devices and, in particular, additive manufacturing or 3D printing of medical devices, such as catheters and implantable stimulation leads, including splines.
Medical catheters and leads are commonly used to access vascular and other locations within a body and to perform various functions at those locations, for example, delivery catheters may be used to deliver medical devices, such as implantable medical leads. A number of such medical devices are designed to be navigated through tortuous paths in a human body, such as through a patient's vasculature. Medical catheters and leads may be designed to be sufficiently flexible to move through turns, or curves, in the vasculature yet sufficiently stiff, or resilient, to be pushed through the vasculature. In many cases, such as those involving cardiovascular vessels, the route to the treatment or deployment site may be tortuous and may present conflicting design considerations that may require compromises between dimensions, flexibilities, material selection, operational controls, and the like. Further, the medical catheters and leads may include spline features (e.g., spiraling splines) that are used to advance the medical device within the body and/or to anchor it, either temporarily or permanently. These various properties can present challenges in designing and manufacturing such catheters and leads.
Existing manufacturing processes, such as polymer molding techniques, may provide challenges with forming splines extending from catheters and leads. Further, forming splines from varying materials and having varying shapes and orientations relative to the catheters and leads may also prove challenging using polymer molding techniques.
The techniques of the present disclosure generally relate to additive manufacturing of medical devices, such as catheters and leads, that allows for forming one or more splines that extend from an outer surface of the catheter/lead. For example, the one or more splines may be formed using additive manufacturing or three-dimensional (3D) printing. Therefore, the one or more splines may be made of various different materials (e.g., exhibiting various degrees of hardness) that may be the same or different material as the catheter and/or lead upon which the one or more splines are positioned. Further, the one or more splines may extend along a helical path on the outer surface of the catheter and/or lead.
An illustrative elongate implantable medical apparatus may include a base element and at least one spline. The base element many extend along a longitudinal direction between a distal end and a proximal end. The base element may include a first material and may include a lumen therein. The at least one spline may protrude from an outer surface of the base element at least proximate to the distal end only partially covering the outer surface. The at least one spline may include a second material. The first material may define a first Shore durometer that is different than a second Shore durometer of the second material.
In one or more embodiments, the at least one spline may extend along a helical path on the outer surface of the base element.
In one or more embodiments, the at least one spline may include a plurality of splines extending along the longitudinal direction.
In one or more embodiments, the base element may include at least one of a braided wire, inner liner.
An illustrative elongate implantable medical apparatus may include a base element and at least one spline. The base element may extend along the longitudinal direction between a distal end and a proximal end. The base element may include a first material and may define a lumen therein. The at least one spline may protrude from an outer surface of the base element at least proximate to the distal end. The at least one spline may include a second material and the second material may include a bioresorbable material.
In one or more embodiments, the second material may include a steroid material.
In one or more embodiments, the second material may include a drug and a polymer.
In one or more embodiments, the second material may include a drug in a porous silicone material.
An illustrative elongate implantable medical apparatus may include a base element and at least one spline. The base element may extend along the longitudinal direction between a distal end and a proximal end. The base element may include a first material and may define a lumen therein. The at least one spline may protrude from an outer surface of the base element at least proximate to the distal end. The at least one spline may include a second material and the second material may include a steroid material.
An illustrative elongate implantable medical apparatus may include a base element and at least one spline. The base element may extend along a longitudinal direction between a distal end and a proximal end. The base element may define a lumen therein. The at leas one spline may protrude from an outer surface of the base element at least proximate to the distal end. The at least one spline may include a first longitudinal section extending along the longitudinal direction and including a first material, and a second longitudinal section extending along the longitudinal direction and including a second material. The first longitudinal section may be proximate or adjacent to the second longitudinal section.
In one or more embodiments, the at least one spline may extend along a helical path on the outer surface of the base element.
In one or more embodiments, the at least one spline may include a plurality of splines extending along the longitudinal direction.
In one or more embodiments, the first material may define a first Shore durometer that is different than a second Shore durometer of the second material.
An illustrative elongate implantable medical apparatus may include a base element and at least one spline. The base element may extend along a longitudinal direction between a distal end and a proximal end. The base element may include a first portion extending along the longitudinal direction and including a first material, and a second portion extending along the longitudinal direction and including a second material. The first portion may extend proximate or adjacent to the second portion. The base element may define a lumen therein. The at least one spline may protrude from an outer surface of at least one of the first portion and the second portion at least proximate to the distal end.
In one or more embodiments, the at least one spline may extend along a helical path on the outer surface of the base element.
In one or more embodiments, the at least one spline may include a plurality of splines extending along the longitudinal direction.
In one or more embodiments, the first material may define a first Shore durometer that is different than a second Shore durometer of the second material.
In one or more embodiments, the at least one spline may include a first spline and, optionally, a second spline. The first spline may include the first material and may protrude from the outer surface of the first portion. The optional second spline may include the second material and may protrude from the outer surface of the second portion.
In one or more embodiments, the first portion and the second portions may extend along a helical path.
In one or more embodiments, the at least one spline may include a third material that is different than the first and second materials.
An illustrative elongate implantable medical apparatus may include a base element and at least one spline. The base element may extend along a longitudinal direction between a distal end and a proximal end. The base element may define a lumen therein. The at least one spline may protrude from an outer surface of the base element at least proximate to the distal end. The at least one spline may define a fluid flow channel extending along the longitudinal direction. The at least one spline may be configured to protect from tissue intrusion into the fluid flow channel when the apparatus is implanted.
In one or more embodiments, the at least one spline may be configured to deflect toward the outer surface of the base element when the apparatus is implanted such that a surface of the at least one spline may define the fluid flow channel between the at least one spline and the outer surface of the base element.
In one or more embodiments, the at least one spline may define an outermost surface in a radial direction and the fluid flow channel may be defined by a recess in the outermost surface.
In one or more embodiments, the apparatus may also include a hydrophilic material disposed in the recess of the at least one spline.
In one or more embodiments, the apparatus may also include a hydrophilic material disposed on the at least one spline.
An illustrative elongate implantable medical apparatus may include a base element and at least one spline. The base element may extend along a longitudinal direction between a distal end and a proximal end. The base element may define a lumen therein. The at least one spline may protrude from an outer surface of the base element at least proximate to the distal end. The at least one spline may define a spline lumen extending through the at least one spline. The at least one spline may include a flexible material such that the at least one spline is inflatable.
In one or more embodiments, the at least one spline may include a first portion including a first material defining a first Shore durometer and a second portion including the flexible material defining a second Shore durometer less than the first Shore durometer. The second portion may be disposed radially distal to the first portion.
In one or more embodiments, the base element may include a first material defining a first Shore durometer and the flexible material defining a second Shore durometer less than the first Shore durometer.
An illustrative elongate implantable medical apparatus may include a base element and at least one spline. The base element may extend along a longitudinal direction between a distal end and a proximal end. The base element may define a lumen therein and the base element may include a flexible material such that the base element is inflatable. The at least one spline may protrude from an outer surface of the base element at least proximate to the distal end. The at least one spline may include a flexible material such that the at least one spline is expandable.
An illustrative elongate implantable medical apparatus may include a base element and at least one spline. The base element may extend along a longitudinal direction between a distal end and a proximal end. The base element may define a lumen therein. The at least one spline may protrude from an outer surface of the base element at least proximate to the distal end. The at least one spline may include a first spline extending along a first helical path and a second spline extending along a second helical path extending in an opposite rotational direction than the first helical path such that the first spline and the second spline intersect.
In one or more embodiments, the first spline may protrude from the outer surface in a radial direction by a first distance greater than a second distance the second spline protrudes from the outer surface.
In one or more embodiments, the second spline may protrude from the outer surface in a direction towards the proximal end.
In one or more embodiments, the first spline may include a first material and the second spline may include a second material. The first material may define a first Shore durometer that is less than a second Shore durometer of the second material.
An illustrative method for additive manufacturing of an implantable medical catheter may include feeding a substrate through a substrate channel in a heating cartridge. The substrate channel in fluid communication with an interior cavity of the heating cartridge. Also, the method may include feeding at least a first filament through a filament port into the interior cavity, melting the first filament in the interior cavity, and moving the heating cartridge relative to the substrate at least in a longitudinal direction and a first rotational direction to form a catheter jacket and a first spline protruding from an outer surface of the catheter jacket comprising material from the first filament. The first spline may extend along a first helical path. Further, the method may include moving a funnel element relative to the substrate at least in a longitudinal direction and a second rotational direction opposite to the first rotational direction to form a second spline protruding from the outer surface of the catheter jacket comprising material from the first spline. The second spline may extend along a second helical path extending in an opposite rotational direction than the first helical path such that the first spline and the second spline intersect.
An illustrative elongate implantable medical apparatus may include a base element and at least one spline. The base element may extend along a longitudinal direction between a distal end and a proximal end. The base element may define a lumen therein. The at least one spline may protrude from an outer surface of the base element at least proximate to the distal end. The at least one spline may define a textured outermost surface to facilitate implantation.
In one or more embodiments, the textured outermost surface may define a plurality of dimples.
In one or more embodiments, the textured outermost surface may define a cross-hatch.
In one or more embodiments, the textured outermost surface may define a plurality of microgrooves.
The details of one or more aspects of the disclosure are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the techniques described in this disclosure will be apparent from the description and drawings, and from the claims.
The present disclosure generally provides additive manufacturing systems and methods for medical devices, such as catheters and leads, that provides one or more splines extending from an outer surface of the medical device. The one or more splines may be configured in a variety of different ways depending on the application. For example, the one or more splines may be formed from a different or same material as the remainder of the medical device. Also, for example, each spline of the one or more splines (or portions of each spline) may be made from one or more materials. Specifically, the different or same materials may define various characteristics (e.g., hardness). Further, for example, the one or more splines may include bioresorbable materials or drug materials. In one or more embodiments, the one or more splines may include a hydrophilic material to assist in advancing the medical device within the patient.
The one or more splines may be formed on the medical device using additive manufacturing techniques, which may, for example, be described as three-dimensional (3D) printing. The additive manufacturing techniques may allow for the one or more splines to be formed on the medical device in a way such that the one or more splines include the characteristics and features described herein (e.g., different materials, configurations, etc.).
For example, a base element of the medical device (e.g., a catheter jacket) and the one or more splines, which extend or protrude from the base element, may include (e.g., be formed of) various materials that may be the same or different from each other. Further, a portion of the base element may be the same or different material as another portion of the base element. Also, a portion of the one or more splines may be the same or different materials as another portion of the one or more splines. Therefore, the medical device (e.g., including the one or more splines) may be customizable or optimizable for a specific application depending on characteristics of the materials used to form one or both of the base element and the splines.
Specifically, in one embodiment, the materials forming the base element may define a hardness that is different than a material forming the one or more splines. In other words, different portions of the base element and the splines may define a softer (e.g., rigid resilient) or harder (e.g., stiffer) material. As such, the material of base element may define characteristics for a specific anatomy requirement (e.g., pushability, flexibility, torque transfer, etc.) and the material of the splines may define characteristics for advancing the shaft or anchoring it in a specific body tissue. Therefore, the characteristics of the device may be specifically customized to a particular application.
In one or more embodiments, the medical device may include sections of alternating materials (e.g., having different characteristics) produced through additive manufacturing techniques. For example, the medical device may alternate between relatively softer and relatively harder sections of the medical device. Specifically, one or both of the base element and the one or more splines may alternate materials in subsequent sections. For example, the base element may alternate materials at segmented sections while the one or more splines is formed from a single material. Further, for example, the base element may be a single material while the one or more splines alternate materials at segmented sections. Still further, for example, both the base element and the one or more splines may alternate materials (e.g., such that material of the base element and the one or more splines is consistent at the same location) at segmented sections. In one or more embodiments, the segmented sections may be defined along a helical path. The sections (e.g., oriented in a “zebra-stripe pattern”) may assist in increasing the shaft flexure while allowing a stiffer spline to transfer torque.
As used herein, the term “or” refers to an inclusive definition, for example, to mean “and/or” unless its context of usage clearly dictates otherwise. The term “and/or” refers to one or all of the listed elements or a combination of at least two of the listed elements.
As used herein, the phrases “at least one of” and “one or more of” followed by a list of elements refers to one or more of any of the elements listed or any combination of one or more of the elements listed.
As used herein, the terms “coupled” or “connected” refer to at least two elements being attached to each other either directly or indirectly. An indirect coupling may include one or more other elements between the at least two elements being attached. Either term may be modified by “operatively” and “operably,” which may be used interchangeably, to describe that the coupling or connection is configured to allow the components to interact to carry out described or otherwise known functionality. For example, a controller may be operably coupled to a resistive heating element to allow the controller to provide an electrical current to the heating element.
As used herein, any term related to position or orientation, such as “proximal,” “distal,” “end,” “outer,” “inner,” and the like, refers to a relative position and does not limit the absolute orientation of an embodiment unless its context of usage clearly dictates otherwise.
All scientific and technical terms used herein have meanings commonly used in the art unless otherwise specified. The definitions provided herein are to facilitate understanding of certain terms used frequently herein and are not meant to limit the scope of the present disclosure.
Reference will now be made to the drawings, which depict one or more aspects described in this disclosure. However, it will be understood that other aspects not depicted in the drawings fall within the scope of this disclosure. Like numbers used in the figures refer to like components, steps, and the like. However, it will be understood that the use of a reference character to refer to an element in a given figure is not intended to limit the element in another figure labeled with the same reference character. In addition, the use of different reference characters to refer to elements in different figures is not intended to indicate that the differently referenced elements cannot be the same or similar.
The base element 110 may include (e.g., be formed of) any suitable material. For example, in one or more embodiments, the base element 110 may include a polymer material. Specifically, the base element 110 may include a thermoplastic material, a thermoset polymeric material, thermoplastic polyurethanes, nylons, nylon copolymers (e.g., Arkema Pebax® which may include block copolymers including rigid polyamide blocks and soft polyether blocks), polyethylene teraphthalate, polybutylene teraphthalate, polyvinylidene fluoride, Chronoprene®, butyl rubber (e.g., a copolymer of isobutylene and isoprene), high density polyethylene, silicone, polyimide, conductive polymers (e.g., such as PEDOT, poly(3,4-ethylenedioxythiophene), or thermoplastics with high loadings of carbon black), etc., or combinations thereof. In one or more embodiments, nylons may include, for example, polyamides, PA-12, PA-6, PA-6/6, with or without fillers, and the nylons may be reinforced with glass fibers, glass beads, and carbon fibers to improve their mechanical and thermal performance.
In one or more embodiments, the apparatus 100 may further include a support element 120 positioned, or located, within the lumen 115 of the base element 110 to provide a structure upon which the base element 110 may be positioned or constructed. The support element 120 may also be described as providing shaft reinforcement to, e.g., transfer torque of the apparatus 100 when in use. The support element 120 may extend along the longitudinal direction 101 between the distal end 104 and the proximal end 102. The support element 120 may be optional and is shown in broken lines in
The apparatus 100 may also include at least one spline 130 protruding from an outer surface 111 of the base element 110. The at least one spline 130 may be located at least proximate to the distal end 104 of the base element 110. The at least one spline 130 may assist in advancing the medical apparatus, or device, 100 within the body of a patient and/or to anchor the medical apparatus 100, either temporarily or permanently. The at least one spline 130 may extend for any suitable length along the base element 110. For example, the at least one spline 130 may extend along the longitudinal axis 101 for a distance for which the apparatus 100 may exit an access catheter, backup catheter or introducer sheath. In one or more embodiments, the length of the at least one spline 130 extending along the longitudinal axis 101 may be determined as to limit the amount of friction that may be created between the at least one spline 130 and the tissue when implanted (e.g., to prevent inhibiting advancement of the catheter or lead).
As shown in
The length of the at least one spline 130 may depend on the indicated use, resulting in various different desired ratios of spline length to base element diameter. For example, the ratio may be variable, resulting in an envelope on a graph depicting spline longitudinal length and the base element diameter. Specifically, in some applications, the device 100 may traverse various sharp turns, therefore, the at least one spline 130 may include multiple spline segments (e.g., as compared to one longer spline segment starting at the distal end 104) along the longitudinal direction to provide improved performance in reaching a target location in the anatomy. As the splines engage tissue of the anatomy, the splines may also create friction that may be overcome in order to rotate-to-advance. In such embodiments, multiple spline segments may help to “pull” the catheter delivery system along at different longitudinal locations of the shaft. As such, the material section of the splines may help keep the friction down so there is a balance between coefficient of friction, spline height and pitch. Further, lubricious coatings (e.g., hydrophilic coatings) may assist in optimizing the friction.
In one or more embodiments, the at least one spline 130 may only partially cover the outer surface 111 of the base element 110. For example, as shown in the cross-sectional view of
In other embodiments, the at least one spline may include a spline layer 131 that covers the base element 110. For example, as shown in the cross-sectional view of
The medical apparatus 100 may be manufactured in any suitable way. For example, the base element 110 may be constructed using additive manufacturing as described in U.S. Pat. App. No. 62/927,092, entitled “ADDITIVE MANUFACTURING FOR MEDICAL DEVICES,” which is herein incorporated by reference. Further, the at least one spline 130 may similarly be manufactured using an additive process. Specifically, in one or more embodiments, the base element 110 and the at least one spline 130 may be formed during a single pass of a heating cartridge, which heats one or more filament materials and forms the materials into the desired shape (e.g., of the base element 110 and the at least one spline 130). In other embodiments, the base element 110 may be formed during a first pass of the heating cartridge and the at least one spline 130 may be formed during a second pass of the heating cartridge (e.g., without moving or manipulating the base element 110 before the second pass), which may be described as a one setup process. In one or more embodiments, the heating cartridge may include an extrusion die of static or dynamic profile that forms filament materials to the desired catheter jacket profile.
Further, in one or more embodiments, the catheter segments on which the splines 130 are formed may be extruded at a larger outside diameter that could then be laser ablated to result in splines, cross-splines, etc. protruding from the same base outside diameter as the non-spline segment (e.g., the base element 110). Also, for example, in forming cross-splines (e.g., as shown in
The at least one spline 130 may extend along the longitudinal direction 101 along any suitable path. For example, as shown in
The at least one spline 130 may include any number (e.g., a plurality) of splines (e.g., portions of a contiguous spline). For example, as shown in
The at least one spline 130 may include (e.g., be formed of) any suitable material. For example, in one or more embodiments, the at least one spline 130 may include a polymer material. Specifically, the at least one spline 130 may include a thermoplastic material, a thermoset polymeric material, a bioresorbable material, a steroid, a hydrophilic coating, a heparin coating (e.g., to manage the average clotting time), etc., or combinations thereof.
It may be described that the base material 110 includes (e.g., is formed of) a first material and the at least one spline 130 includes (e.g., is formed of) a second material, where the first material is different from the second material. In one or more embodiments, the first material (of the base element 110) may define a first Shore durometer that is different than a second Shore durometer of the second material (of the at least one spline 130). For example, the first material may define a first Shore durometer that is less (e.g., softer) than a second Shore durometer of the second material. As such, the base element 110 may be softer than the at least one spline 130 (e.g., such that the base element 110 defines the appropriate characteristics of pushability, flexibility, and/or torque transfer and the at least one spline 130 defines the appropriate characteristics for advancing and/or anchoring). Also, in one or more embodiments, the first material may define a first Shore durometer that is greater (e.g., harder) than a second Shore durometer of the second material.
In one or more embodiments, the material forming one or both of the base element 110 and the at least one spline 130 may include a bioresorbable material. In one or more embodiments, the material forming one or both of the base element 110 and the at least one spline 130 may include a steroid material. In one or more embodiments, the material forming one or both of the base element 110 and the at least one spline 130 may include a drug and a polymer. In one or more embodiments, the material forming one or both of the base element 110 and the at least one spline 130 may include a drug in a porous silicone material. For example, the at least one spline 130 may include a specific drug to silicone composition such that the drug may be released into the surrounding tissue in a controlled manner.
Each of these additional materials may be disposed on the apparatus 100 in any suitable way. For example, the medical apparatus 100 may be constructed using additive manufacturing as described in U.S. Pat. App. No. 62/927,092, entitled “ADDITIVE MANUFACTURING FOR MEDICAL DEVICES,” which is herein incorporated by reference. Therefore, the additional material (e.g., bioresorbable material, steroid material, drug, etc.) may be printed on the medical apparatus 100 by, e.g., pixel-by-pixel 3D printing, using multiple print heads, through a multi-layer process, etc.
Bioresorbable material may be used on splines of a sleevehead of a cardiac pacing lead with spiral splines to provide additional fixation with active fixation leads, which may facilitate screwing the lead deeper into the myocardium or to anchor a lead deep in the coronary veins such as the septal vein. Sleeveheads may be molded polyurethane components located between the distal cathode and the anode ring. The bioresorbable material may be incorporated the spiral fixation splines, for example, to facilitate removability of the lead. Segments of the spiral splines, which may be described as intermittent spiral splines or “nubs,” may include (e.g., be formed of) the bioresorbable material to increase fixation during implantation. Bioresorbable spiral spline material may include a steroid and, the sleevehead may also include steroid integrated (e.g., 3D printed) into the sleevehead itself, to create an integrated monolithic controlled release device (MCRD).
Specifically, in one or more embodiments, the at least one spline 130 including a steroid material may include porous silicone, which may be impregnated with dexamethasone acetate and may be referred to as a monolithic controlled release device (MCRD). In other embodiments, the at least one spline 130 may include porous polyurethane and other steroids like dexamethasone sodium phosphate and beclomethasone. These configurations may elute steroid along an exponentially decaying elution curve for years. Additionally, the porous carrier material may remain even when the elution is immeasurable (e.g., after the elution has completely eluted from the carrier).
As shown in
The alternating materials of the medical apparatus 200 may be manufactured in any suitable way. For example, the medical apparatus 100 may be constructed using additive manufacturing as described in U.S. Pat. App. No. 62/927,092, entitled “ADDITIVE MANUFACTURING FOR MEDICAL DEVICES,” which is herein incorporated by reference. Specifically, the alternating materials may be formed by pixel-by-pixel 3D printing, using multiple print heads.
Further, as shown in
For example, the apparatus 200 may be customized for a particular flexure (e.g., bending) and torque transfer. Specifically, in certain applications, alternating the pattern of hard and soft polymers may, for example, assist in tracking the anatomy better, provide for increased torque transfer (as compared to soft polymer alone at the distal end), and not stretch excessively when pulling the catheter through tortuous anatomy. Further, an alternating pattern may be a gradient or may be a more discrete transition. For example, a hard/soft continuous spiral spline may have enough flexibility due to the soft segments to manage acute changes in vessel shape and direction while maintaining continuous engagement with the vessel wall through the hard segments of the spline to transfer torque to the irregular-shaped vessel wall. Further, the alternating hard/soft spiral splines may transfer more force to the vessel wall through very localized engagement (e.g., the integration of those small but optimized engagements pull the catheter through the tortuous section when rotating-to-advance).
Also, as shown in
In one or more embodiments, for example as shown in
By altering one or both of the materials forming the base elements 210, 310 and the materials forming the at least one spline 230, 330, the apparatus 200, 300 may be customized for a specific application. For example, the materials forming the apparatus 200, 300 may define a specific torque to flexure ratio for the specific application (e.g., rigidity to apply a sufficient torque, yet flexible to navigate a tortious path for that application).
As shown in
Additionally,
Further, the fluid flow channel 435 may be constructed based on the specific therapy performed by the medical apparatus 400 or the anatomy to be traversed by the medical apparatus 400. For example, a specific therapy may include tunneling through the ventricular septum and another specific therapy may advance a delivery catheter deep into the coronary venous system through tortuous branches that get smaller and smaller in dimension as the delivery catheter is advanced deeper.
In one or more embodiments, the at least one spline 430 may be configured to deflect toward the outer surface 411 of the base element 410 when the apparatus 400 is implanted, e.g., as indicated by arrow 449 shown in
In one or more embodiments, the at least one spline 430 may define an outermost surface 438 (e.g., in a radial direction) and the fluid flow channel 435 may be defined by a recess in the outermost surface 438, e.g., as shown in
In one or more embodiments, fluid flow channel 435 may have an extended surface to increase attachment sites or the fluid flow channel 435 may incorporate a matrix to assist in holding the cross-linked hydrogel or hydrophilic material in the fluid flow channel 435 (e.g., to increase the durability of the hydrophilic coating). Further, ozone, corona, or plasma surface pre-treatment may be used to improve covalent bonding to the substrate. Some hydrophilic coatings may be cured using ultraviolet light after being deposited on the surface. The hydrophilic coating deposition may be preceded by printing a tie-layer material miscible to the substrate and to the hydrophilic material for improved durability or to attach the hydrophilic material to a hydrophobic substrate material. In one or more embodiments, two types of hydrophilic materials may be printed onto the surface (e.g., of the fluid flow channel 435), with one hydrophilic material printed on a first surface of the fluid flow channel 435 and the other one printed on a second surface of the fluid flow channel 435 that is different from the first surface. The hydrophilic material in the fluid flow channel 435 may swell more and provide fluid in high contact stress locations to flow towards a more durable hydrophilic material which does not swell as much.
As shown in
The at least one spline 530 may define a spline lumen 540 extending through the at least one spline 530. Further, the at least one spline 530 may include a flexible material (e.g., flexible relative to the remainder of the apparatus 500) such that the at least one spline 530 may be inflatable (e.g., by inserting fluid through the spline lumen 540). In one or more embodiments, the at least one spline 530 may include a first portion 542 formed from a first material and a second portion 544 formed from a second material. The second portion 544 may be disposed radially distal to the first portion 542 (e.g., the second portion is outside of or exterior to the first portion). The first material may define a first Shore durometer and the second material may define a second Shore durometer less than the first Shore durometer. Therefore, the outermost material (e.g., the second portion 544) of the at least one spline 530 may allow for the at least one spline 530 to inflate when a fluid is inserted into the spline lumen 540. In other embodiments, the first and second materials may be formed from the same flexible material.
The at least one spline 530 may be manufactured to be inflatable in any suitable way. For example, the medical apparatus 500 may be constructed using additive manufacturing as described in U.S. Pat. App. No. 62/927,092, entitled “ADDITIVE MANUFACTURING FOR MEDICAL DEVICES,” which is herein incorporated by reference, and the at least one spline 530 may include further processing. For example, in one or more embodiments, a thin wall of highly elastic material, such as a biocompatible elastomer, may be extruded over a core rod (e.g., made of copper). The biocompatible elastomer may be placed through an extruder longitudinal for each spline of the at least one spline 530. The biocompatible elastomer may then be moved through either a die cut out for the at least one spline 530 or through a die with no cut outs (e.g., no splines). During a second pass, a second material may be placed, or formed, thereon (e.g., if the proximal and medial portions are not to be inflatable) and transitioned to a biocompatible elastomer for the portion of the at least one spline 530 that is inflatable (e.g., the balloon portion of the at least one spline 530). The core rod may then be stretched and pulled out of the middle of the at least one spline 530, forming a lumen. Next, a distal tip may be mold inserted to close off the lumen of the at least one spline 530. Also, a hub may be mold inserted to create an inflation manifold in fluid communication with the lumen (e.g., therefore using a Luer fitting to attach an inflator or a syringe).
In another embodiment, the at least one inflatable spline 530 may be manufactured using pixel-by-pixel 3D printing. In such embodiments, the at least one spline 530 may include a post-printing cure, sealer, or binder. Further, if the at least one inflatable spline 530 is created by multiple passes, tie layers may be used, having potentially different size pixels (e.g., different shot sizes), etc.
Further, in one or more embodiments, the base element 510 may include a flexible material such that the base element 510 is inflatable (e.g., the apparatus 500 may not include support element such as a braid or reinforcement underneath the base element 510 at the inflatable portion). In such embodiments, the at least one spline 530 may be formed from a flexible material such that the at least one spline is expandable (e.g., when the base element 510 is inflated).
The inflatable spline 530 (e.g., as shown in
In one or more embodiments, the spline lumen 540 (e.g., shown in broken lines) may extend from a proximal end 502 to the distal end 504, e.g., as shown in
Further, in one or more embodiments, the apparatus 500 may define a tubular filament spline 530 that may be wound onto the base element 510, e.g., as shown in
It is noted that the embodiments illustrated in
As shown in
The at least one spline 630 may include a first spline 652 extending along a first helical path and a second spline 654 extending along a second helical path. The second helical path may be defined as extending in an opposite rotational direction than the first helical path such that the path of the first spline 652 and the path of the second spline 654 intersect. In one embodiment, the first and second splines 652, 654 may contact and intersect.
However, in another embodiment, the first and second splines 652, 654 do not physically contact, but the paths upon which the first and second splines 652, 654 extend cross one another. Therefore, in this embodiment, the first spline 652 may be described as continuous, while the second spline 654 may be described as not continuous or segmented.
In one or more embodiments, the first spline 652 may protrude from the outer surface 611 in a radial direction by a first distance 653 that is greater than a second distance 655 that the second spline 654 protrudes from the outer surface 611 (e.g., as shown in
In one or more embodiments, the first spline 652 may be configured to assist in controlling movement of the apparatus 600 and the second spline 654 may be flexible in one direction and restrict specific movement, as described further herein. For example, the second spline 654 may protrude from the outer surface 611 at an angle towards the proximal end 602. Therefore, when the medical apparatus 600 (e.g., the distal end 604) is inserted into a patient, the second spline 654 may deflect towards the outer surface 611. However, when the medical apparatus 600 is moved in the opposite direction (e.g., towards the proximal end 602), the second spline 654 may engage the tissue within which the apparatus 600 is positioned to, e.g., restrict movement, etc.
Each of the first and second splines 652, 654 may include the same or different material. For example, the first spline 652 may include (e.g., be formed of) a first material and the second spline 654 may include (e.g., be formed of) a second material. In one or more embodiments, the first material may define a first Shore durometer that is less than a second Shore durometer of the second material.
The medical apparatus including cross-spiraling splines (e.g., as shown in
Specifically,
The method may also include moving 810 a funnel element relative to the substrate at least in a longitudinal direction and a second rotational direction opposite to the first rotational direction to form a second spline protruding from the outer surface of the catheter jacket comprising material from the first spline. In other words, the funnel element may move relative to the catheter jacket to “smear” the first material from the first spline to form the second spline. The second spline may extend along a second helical path extending in an opposite rotational direction than the first helical path such that the first spline and the second spline intersect.
For example,
As shown in
Further, the at least one spline 730 may define a textured outermost surface 738 to facilitate implantation of the medical apparatus 700. For example, in one or more embodiments, the textured outermost surface 738 may define a plurality of dimples. Also, in one or more embodiments, the textured outermost surface 738 may define a cross-hatch. Further, in one or more embodiments, the textured outermost surface 738 may define a plurality of micro-grooves or micro-splines. It is noted that, while
While the present disclosure is not so limited, an appreciation of various aspects of the disclosure will be gained through a discussion of the specific examples and illustrative embodiments provided below. Various modifications of the examples and illustrative embodiments, as well as additional embodiments of the disclosure, will become apparent herein.
A1. An apparatus comprising:
A2. The apparatus of embodiment A1, wherein the at least one spline extends along a helical path on the outer surface of the base element.
A3. The apparatus of embodiment A1 or A2, wherein the at least one spline comprises a plurality of splines extending along the longitudinal direction.
A4. The apparatus of any preceding A embodiment, wherein the base element comprises at least one of a braided wire, inner liner.
B1. An apparatus comprising:
B2. The apparatus of embodiment B1, wherein the second material comprises a steroid material.
B3. The apparatus embodiment B1 or B2, wherein the second material comprises a drug and a polymer.
B4. The apparatus of any preceding B embodiment, wherein the second material comprises a drug in a porous silicone material.
C1. An apparatus comprising:
D1. An apparatus comprising:
D2. The apparatus of embodiment D1, wherein the at least one spline extends along a helical path on the outer surface of the base element.
D3. The apparatus of embodiment D1 or D2, wherein the at least one spline comprises a plurality of splines extending along the longitudinal direction.
D4. The apparatus of any preceding D embodiment, wherein the first material defines a first Shore durometer that is different than a second Shore durometer of the second material.
E1. An apparatus comprising:
E2. The apparatus of embodiment E1, wherein the at least one spline extends along a helical path on the outer surface of the base element.
E3. The apparatus of embodiment E1 or E2, wherein the at least one spline comprises a plurality of splines extending along the longitudinal direction.
E4. The apparatus of any preceding E embodiment, wherein the first material defines a first Shore durometer that is different than a second Shore durometer of the second material.
E5. The apparatus of any preceding E embodiment, wherein the at least one spline comprises: a first spline comprising the first material and protruding from the outer surface of the first portion; and optionally a second spline comprising the second material and protruding from the outer surface of the second portion.
E6. The apparatus of any preceding E embodiment, wherein the first portion and the second portions extend along a helical path.
E7. The apparatus of any preceding E embodiment, wherein the at least one spline comprises a third material that is different than the first and second materials.
F1. An apparatus comprising:
F2. The apparatus of embodiment F1, wherein the at least one spline is configured to deflect toward the outer surface of the base element when the apparatus is implanted such that a surface of the at least one spline defines the fluid flow channel between the at least one spline and the outer surface of the base element.
F3. The apparatus of embodiment F1 or F2, wherein the at least one spline defines an outermost surface in a radial direction and the fluid flow channel is defined by a recess in the outermost surface.
F4. The apparatus of embodiment F3, further comprising a hydrophilic material disposed in the recess of the at least one spline.
F5. The apparatus of any preceding F embodiment, further comprising a hydrophilic material disposed on the at least one spline.
G1. An apparatus comprising:
G2. The apparatus of embodiment G1, wherein the at least one spline comprises a first portion comprising a first material defining a first Shore durometer and a second portion comprising the flexible material defining a second Shore durometer less than the first Shore durometer, wherein the second portion is disposed radially distal to the first portion.
G3. The apparatus of embodiment G1 or G2, wherein the base element comprises a first material defining a first Shore durometer and the flexible material defining a second Shore durometer less than the first Shore durometer.
H1. An apparatus comprising:
I1. An apparatus comprising:
I2. The apparatus of embodiment I1, wherein the first spline protrudes from the outer surface in a radial direction by a first distance greater than a second distance the second spline protrudes from the outer surface.
I3. The apparatus of embodiment I1 or I2, wherein the second spline protrudes from the outer surface in a direction towards the proximal end.
I4. The apparatus of any preceding I embodiment, wherein the first spline comprises a first material and the second spline comprises a second material, the first material defining a first Shore durometer that is less than a second Shore durometer of the second material.
J1. A method comprising:
K1. An apparatus comprising:
K2. The apparatus of embodiment K1, wherein the textured outermost surface defines a plurality of dimples.
K3. The apparatus of embodiment K1 or K2, wherein the textured outermost surface defines a cross-hatch.
K4. The apparatus of any preceding K embodiment, wherein the textured outermost surface defines a plurality of microgrooves.
Thus, various embodiments of medical devices including at least one spline extending from an outer surface of the device and along a longitudinal direction and methods to manufacture the same are disclosed. It should be understood that various aspects disclosed herein may be combined in different combinations than the combinations specifically presented in the description and accompanying drawings. It should also be understood that, depending on the example, certain acts or events of any of the processes or methods described herein may be performed in a different sequence, may be added, merged, or left out altogether (e.g., all described acts or events may not be necessary to carry out the techniques). In addition, while certain aspects of this disclosure are described as being performed by a single module or unit for purposes of clarity, it should be understood that the techniques of this disclosure may be performed by a combination of units or modules associated with, for example, a medical device.
In one or more examples, the described techniques may be implemented in hardware, software, firmware, or any combination thereof. If implemented in software, the functions may be stored as one or more instructions or code on a computer-readable medium and executed by a hardware-based processing unit. Computer-readable media may include non-transitory computer-readable media, which corresponds to a tangible medium such as data storage media (e.g., RAM, ROM, EEPROM, flash memory, or any other medium that can be used to store desired program code in the form of instructions or data structures and that can be accessed by a computer).
Instructions may be executed by one or more processors, such as one or more digital signal processors (DSPs), general purpose microprocessors, application specific integrated circuits (ASICs), field programmable logic arrays (FPGAs), or other equivalent integrated or discrete logic circuitry. Accordingly, the term “processor” as used herein may refer to any of the foregoing structure or any other physical structure suitable for implementation of the described techniques. Also, the techniques could be fully implemented in one or more circuits or logic elements.
All references and publications cited herein are expressly incorporated herein by reference in their entirety for all purposes, except to the extent any aspect directly contradicts this disclosure.
Unless otherwise indicated, all numbers expressing feature sizes, amounts, and physical properties used in the specification and claims may be understood as being modified either by the term “exactly” or “about.” Accordingly, unless indicated to the contrary, the numerical parameters set forth in the foregoing specification and attached claims are approximations that can vary depending upon the desired properties sought to be obtained by those skilled in the art utilizing the teachings disclosed herein or, for example, within typical ranges of experimental error.
As used herein, the term “configured to” may be used interchangeably with the terms “adapted to” or “structured to” unless the content of this disclosure clearly dictates otherwise.
The singular forms “a,” “an,” and “the” encompass embodiments having plural referents unless its context clearly dictates otherwise.
As used herein, “have,” “having,” “include,” “including,” “comprise,” “comprising” or the like are used in their open-ended sense, and generally mean “including, but not limited to.” It will be understood that “consisting essentially of,” “consisting of,” and the like are subsumed in “comprising,” and the like.
Reference to “one embodiment,” “an embodiment,” “certain embodiments,” or “some embodiments,” etc., means that a particular feature, configuration, composition, or characteristic described in connection with the embodiment is included in at least one embodiment of the disclosure. Thus, the appearances of such phrases in various places throughout are not necessarily referring to the same embodiment of the disclosure. Furthermore, the particular features, configurations, compositions, or characteristics may be combined in any suitable manner in one or more embodiments.
The words “preferred” and “preferably” refer to embodiments of the disclosure that may afford certain benefits, under certain circumstances. However, other embodiments may also be preferred, under the same or other circumstances. Furthermore, the recitation of one or more preferred embodiments does not imply that other embodiments are not useful and is not intended to exclude other embodiments from the scope of the disclosure.
The present application claims the benefit of U.S. Provisional Application No. 63/001,832, filed Mar. 30, 2020, which is incorporated herein by reference in its entirety.
Number | Date | Country | |
---|---|---|---|
63001832 | Mar 2020 | US |